3 Myalgic Encephalomyelitis Clinical Trials in Worcester, MA (2026)

Q: How do I join a clinical trial in Worcester?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Worcester research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Worcester

NCT07038200Recruiting

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)...

Worcester, MAPHASE3200 participantsAvidity Biosciences, Inc.

View Study Details

NCT06522880Recruiting

Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study

The goal of STAGE I of the CMV TransmIT Study is to determine the prevalence of CMV shedding in children up to and including 36 months of age in large group childcare centers and in staff who regularl...

Worcester, MA100 participantsUniversity of Massachusetts, Worcester

View Study Details

NCT07020819Recruiting

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

The goal of this open label study is to measure pharmacokinetics, pharmacodynamics, early efficacy, and safety of tanruprubart in adult and pediatric participants, in the United States, Canada, and Eu...

Worcester, MAPHASE330 participantsAnnexon, Inc.

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Worcester

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 3 myalgic encephalomyelitis clinical trials recruiting participants in Worcester, MA. These studies are seeking a combined 330 participants. Research is being sponsored by Avidity Biosciences, Inc., University of Massachusetts, Worcester, Annexon, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Worcester — FAQ

Are there myalgic encephalomyelitis clinical trials in Worcester?

Yes, there are 3 myalgic encephalomyelitis clinical trials currently recruiting in Worcester, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Worcester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Worcester research site will contact you about next steps.

Are clinical trials in Worcester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Worcester studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 3 active trials in Worcester are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 22, 2026 from ClinicalTrials.gov